ShareholderTotal shares% ownedCountry
Ronja Capital Investment AS      3 087 999 11,50 %NOR
Capra Invest AS      1 544 450 5,75 %NOR
MRFK Holding AS      1 313 960 4,89 %NOR
J.P. Morgan SE      1 179 448 4,39 %LUX
Vartdal Holding AS      1 040 286 3,87 %NOR
Brødrene Vartdal AS          803 601 2,99 %NOR
Kotler Equity Investment Limited          667 330 2,48 %CHN
Hawk Infinity AS          605 201 2,25 %NOR
Stette Invest AS          602 375 2,24 %NOR
Kjølås Stansekniver AS          574 859 2,14 %NOR
Life Capitol AS          558 531 2,08 %NOR
Ajea Invest AS          555 359 2,07 %NOR
Eros AS          520 240 1,94 %NOR
Strand Fiskeriselskap AS          473 342 1,76 %NOR
Gold Coast Nutrition NUF          460 000 1,71 %NOR
Nordnet Livsforsikring AS          411 822 1,53 %NOR
Altitude Capital AS          394 455 1,47 %NOR
Triplenine Vedde AS          340 000 1,27 %NOR
Melesio Invest AS          315 000 1,17 %NOR
EM-KA AS          292 771 1,09 %NOR
Other    11 118 311 41,39 %
Sum    26 859 340 100,00 %
Updated 30.6.2025

Nominee registered shares

In accordance with current regulations Arctic Bioscience must at least once a year make available to the public an overview of who owns nominee-registered shares in the Company, which country the shareholder is resident in and how many shares each individual owns.

The latest report has been finalized as of 14. April 2025, based on registered shares as of 21. March 2025. This report can be received by sending a request to the Company’s IR Contact.